Complete the calculations for determining working capital. Then tell how the financial statements help determine financial health.

Specifically, you must address the following rubric criteria:

• Financial Statements: Explain the various financial statements needed to calculate a business's working capital. Also explain how to use each financial statement for the calculation. Give examples to support your claims.
• Working Capital's Role: Discuss how businesses that manage their working capital well stay healthy.
• Working Capital Interpretation: Use the correct formula to calculate working capital. Then discuss the business's current financial liquidity position.
  • For example, does the business have enough working capital ready to address bills to suppliers? Will there be potential cash inflow at the end of the year?
• Working Capital Management Trend: Discuss the business's trend in how they manage their working capital.
  • Remember that financial statements reflect a specific period of time and the value of the business's working capital during that period.

As Fleported Quarterly Balance Sheet Fleport Date 04l00l202 4l4l202 1st 1st Currency USE! USE! Audit Status Unaudited Unaudited Consolidated "r'es 'res Scale Thousand Thousand Cash 0: cash equivalents 10400000 120?1000 Marketable securities 10025000 11040000 Accounts receivable. trade. gross 15020000 15200000 Less allowances For douthul accounts 0: credit losses 204000 2?0000 Accounts receivable. trade 15504000 14000000 Flay.I materials 0: supplies 10?0000 155?000 Goods in process 2020000 2004000 Finished goods 0002000 0001000 Inventories 10000000 0052000 Prepaid expenses 0: other current assets 0452000 0024000 Assets held For sale - - Total current assets 00424000 52500000 Property. plant 0: equipment at cost 4??02000 40400000 Less: accumulated depreciation 20001000 20000000 Property. plant 0: equipment. net 10?01000 1000?000 Intangible assets. net 44420000 51110000 Goodwill 04005000 05000000 EIeFerred taxes on income 0000000 0021000 IZIther assets 0000000 0500000 Total assets 1?0055000 1?255T"000 Loans 0: notes payable 420?000 0050000 Accounts payable 0000000 0500000 Accrued liabilities 10000000 10220000 Accrued rebates. returns 0: promotions 120?2000 11010000 Accrued compensation 0: employee related obligations 2000000 2000000 Accrued takes on income 1708000 1877000 Total current liabilities 43390000 40932000 Notes 26859000 28273000 Debentures 1985000 1983000 Other long-term debt 7000 7000 Long-term debt 28851000 30263000 Deferred takes on income 6424000 6507000 Employee related obligations 8739000 10512000 Long-term takes payable 5745000 6568000 Other liabilities 10497000 11941000 Total liabilities 103646000 106723000 Common stock 3120000 3120000 Foreign currency translation -10571000 -8662000 Gain [loss) on securities -16000 1000 Employee benefit plans -2538000 -6724000 Gain [loss) on derivatives & hedges -632000 57000 Accumulated other comprehensive income (loss) -13757000 -15328000 Retained earnings (accumulated deficit) 124380000 116508000 Less: common stock held in treasury, at cost 39034000 38466000 Total shareholders' equity (deficit) 74709000 65834000As Reported Quarterly Income Statement Report Date 04/03/2022 04/04/2021 1st Quarter 1st Quarter Currency USD USD Audit Status Unaudited Unaudited Consolidated Yes Yes Scale Thousands Thousands Sales to customers 23426000 22321000 Cost of products sold 7598000 7063000 Gross profit (loss) 15828000 15258000 Selling, marketing & administrative expenses 5938000 5432000 Research & development expense 3462000 3178000 In-process research & development expenses 610000 Interest income 22000 15000 Interest expense, net of portion capitalized 10000 63000 Other income (expense), net 102000 882000 Restructuring expenses 70000 53000 Earnings (loss) before provision for taxes on income 5862000 7429000 Provision (benefit) for taxes on income 713000 1232000 Net earnings (loss) 5149000 6197000 Weighted average shares outstanding - basic 2629200 2631600 Weighted average shares outstanding - diluted 2666500 2672700 Year end shares outstanding 2629384 2632702 Net earnings (loss) per share - basic 1.96 2.35 Net earnings (loss) per share - diluted 1.93 2.32 Cash dividends per share 1.06 1.01Report Date 04/03120 04104120 As Reported Quarterly Cash Flow 1st Ist Scale Thousand Thousand Net earnings (loss) 5143000 5197000 Depreciation & amortization of property & intangibles 1769000 1894000 Stock based compensation 278000 307000 Asset write-downs 610000 14000 Contingent consideration reversal Net loss [ gain ) on sale of assets or businesses -168000 -580000 Deferred tax provision (benefit) -926000 -730000 Credit losses & accounts receivable allowances 6000 -13000 Accounts receivable -427000 -1604000 Inventories -600000 -695000 accounts payable & accrued liabilities -2817000 2336000 Other current & non-current assets 395000 2522000 Other current & non-current liabilities 110000 -902000 Net cash flows from operating activities 3973000 4074000 Additions to property, plant & equipment -607000 -677000 Proceeds from the disposal of assets or businesses, net 248000 603000 Acquisitions, net of cash acquired -252000 Purchases of investments -3018000 -5934000 Sales of investments 6303000 5233000 Credit support agreements activity, net -243000 751000 Other investing activities Other investing activities ( primarily licenses & milestones) 53000 101000 Net cash flows from investing activites 3634000 -185000 Dividends to shareholders -2787000 -2653000 Repurchase of common stock -1577000 -1438000 Proceeds from short-term debt 3013000 23000 Repayment of short-term debt -856000 -475000 Proceeds from long-term debt, not of issuance costs 1000 Repayment of long-term debt -2132000 -1001000 Proceeds from the exercise of stock options or employee 321000 236000 Credit support agreements activity, net -235000 212000 Other financing activities -138000 -24000 Net cash flows from financing activities -4385000 -5125000 Effect of exchange rate changes on cash & cash equivalent 16000 -78000 Increase ( decrease) in cash & cash equivalents -4024000 -1314000 Cash & cash equivalents, beginning of period 14487000 13985000 Cash & cash equivalents, end of period 10463000 12671000